Welcome to the

HW210601 22372 - Supply Chain & Logistics for Cell Therapies Summit logo-min

The community will gather to network, share exclusive insights in case-study led sessions, and propose best practice for seamless vein-to-vein delivery at the clinical and commercial scale.

Implement robust, patient-centric supply chains for clinical to commercial readiness

  • Build your supply strategy and manage risk and forecasting at scale by designing for growth
  • Maximize your cloud-based and integrated systems and hear the latest innovations in chain of identity
  • Manage materials, external manufacturing and facility design

Optimize patient care with best practice guidelines and integrated platforms

  • Understand clinical requirements and develop clinical strategies for seamless therapeutic delivery
  • Discuss and establish industry best practices and understand which standard practices can apply across a range of cell modalities

Maintain product quality at scale for seamless delivery of autologous and allogeneic 

  • Optimize front-end processes and develop patient care organisations
  • Discuss quality control and site audits to ensure best standard of care and product quality

Previous Attending Companies:

Supply for Cell Immunotherapies Summit - companies attending

World-Class Speaker Faculty

Christopher Baldwin

Supply Chain Director, Cell Tx


Craig Beasley

VP Supply Chain, Cell Tx

Bristol Myers Squibb

Karen Moniz

Technical Director


Peter Olagunju

SVP Technical Operations


Delfi Krishna

Head of Strategic Operations Cell & GTx


Nicole Rickard

Head of Supply Chain, Cell & GTx

Vertex Pharmaceuticals

Paul Staid

VP, Cell Therapy Supply Chain

Bristol Myers Squibb

Sebastian Schneider

Strategy Lead Cell & GTx Industrialization


Proud to Partner With